-
公开(公告)号:US20250009722A1
公开(公告)日:2025-01-09
申请号:US18889824
申请日:2024-09-19
Inventor: Joel M. Trugman , Ramesh Boinpally , Abhijeet Jakate , Michelle Finnegan , Mary Ann Johnson , Leonardo R. Allain , W. Mark Eickhoff , Craig B. Ikeda , Chad D. Brown , Francis J. Flanagan , Rebecca Nofsinger , Melanie Marota , Lisa Lupton , Paresh B. Patel , Hanmi Xi , Wei Xu
IPC: A61K31/4375 , A61K31/4545 , A61P25/06
Abstract: The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and/or P-gp only inhibitors.
-
公开(公告)号:US20240417408A1
公开(公告)日:2024-12-19
申请号:US18564799
申请日:2022-05-27
Applicant: MERCK SHARP & DOHME CORP.
Inventor: Kazuaki SHIBATA , Yu KOBAYAKAWA , Tadashi IMAOKA , Toshihiro SAKAMOTO , Risako MIURA , Elisabeth HENNESSY , Juan DEL POZO
IPC: C07D491/052 , A61K31/519 , A61K31/5377 , A61K31/55 , A61K45/06 , A61P35/00 , C07D519/00
Abstract: Compounds of Formula (I) or their pharmaceutically acceptable salts can inhibit the G12C mutant of Kirsten rat sarcoma (KRAS) protein and are expected to have utility as therapeutic agents, for example, for treating cancer. The disclosure also provides pharmaceutical compositions which comprise compounds of Formula (I) or pharmaceutically acceptable salts thereof. The disclosure also relates to methods for use of the compounds or their pharmaceutically acceptable salts in the therapy and prophylaxis of cancer and for preparing pharmaceuticals for this purpose.
-
公开(公告)号:US20240366575A1
公开(公告)日:2024-11-07
申请号:US18776516
申请日:2024-07-18
Inventor: Joel M. Trugman , Ramesh Boinpally , Abhijeet Jakate , Michelle Finnegan , Mary Ann Johnson , Leonardo R. Allain , W. Mark Eickhoff , Craig B. Ikeda , Chad D. Brown , Francis J. Flanagan, JR. , Rebecca Nofsinger , Melanie Marota , Lisa Lupton , Paresh B. Patel , Hanmi Xi , Wei Xu
IPC: A61K31/4375 , A61K31/4545 , A61P25/06
Abstract: The present disclosure provides methods for the acute treatment of migraine with or without aura, comprising the administration of ubrogepant. In particular, the present disclosure provides methods for the acute treatment of migraine in patients having hepatic impairment; in patients with renal impairment; and in patients concurrently taking CYP3A4 modulators or BCRP and/or P-gp only inhibitors.
-
公开(公告)号:US20230416266A1
公开(公告)日:2023-12-28
申请号:US18038367
申请日:2021-11-23
Applicant: Merck Sharp & Dohme Corp.
Inventor: Yongxin Han , Elisabeth Hennessy , Andrew J. Hoover , Jesus Moreno , Uma Swaminathan
IPC: C07D491/052 , A61P35/00
CPC classification number: C07D491/052 , A61P35/00
Abstract: The disclosure provides compounds of Formula (I)
or a pharmaceutically acceptable salt thereof, wherein W1, W2, Y, Z, CA, R1, R2a, and R2b are as described herein. The compounds or their pharmaceutically acceptable salts can inhibit the G12C mutant of Kirsten rat sarcoma (KRAS) protein and are expected to have utility as therapeutic agents, for example, for treating cancer. The disclosure also provides pharmaceutical compositions which comprise compounds of Formula (I) or pharmaceutically acceptable salts thereof. The disclosure also relates to methods for use of the compounds or their pharmaceutically acceptable salts in the therapy and prophylaxis of cancer and for preparing pharmaceuticals for this purpose.-
公开(公告)号:US11738010B2
公开(公告)日:2023-08-29
申请号:US17385258
申请日:2021-07-26
Applicant: MERCK SHARP & DOHME CORP.
Inventor: John P. Caldwell , Reynalda De Jesus , Fa-Xiang Ding , Charles J. Gill , Ginny Dai Ho , Sookhee N. Ha , Sandra J. Koseoglu , Marc A. Labroli , Sang Ho Lee , Christina Madsen-Duggan , Mihir Mandal , Terry Roemer , Jing Su , Christopher Michael Tan , Zheng Tan , Haifeng Tang , Hao Wang , Christine Yang , Shu-Wei Yang
IPC: A61K31/4439 , A61P31/04 , A61K31/407 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/431 , A61K31/4375 , A61K31/438 , A61K31/4709 , A61K31/5377 , A61K31/5383 , C07D263/26 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D491/048 , C07D495/04 , C07D498/04
CPC classification number: A61K31/4439 , A61K31/407 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/431 , A61K31/438 , A61K31/4375 , A61K31/4709 , A61K31/5377 , A61K31/5383 , A61P31/04 , C07D263/26 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D491/048 , C07D495/04 , C07D498/04
Abstract: Novel compounds of the structural formula I, and the pharmaceutically acceptable salts thereof, are inhibitors of TarO and may be useful in the prevention, treatment and suppression of diseases mediated by TarO, such as bacterial infections, including gram negative bacterial infections and gram positive bacterial infections such as MRSA and MRSE, alone or in combination with a β-lactam antibiotic.
-
公开(公告)号:US20230192876A1
公开(公告)日:2023-06-22
申请号:US17772229
申请日:2020-10-29
Applicant: Merck Sharp & Dohme Corp.
Inventor: Elliot K. Chartash , Amy M. Beebe , Jason K. Cheung , Konstantin Dobrenkov , Claire H. Li , Richard Wnek
IPC: C07K16/28 , A61P35/00 , A61K39/395 , A61K31/282 , A61K31/519
CPC classification number: C07K16/2878 , A61P35/00 , C07K16/2818 , C07K16/2827 , A61K39/3955 , A61K31/282 , A61K31/519 , A61K2039/505
Abstract: The present invention relates to methods of treating cancer by administering an anti-CD27 antibody as a monotherapy or as a part of a combination thereof.
-
公开(公告)号:US20230129710A1
公开(公告)日:2023-04-27
申请号:US17913920
申请日:2021-03-25
Applicant: Simon Fraser University , Merck, Sharp & Dohme Corp.
Inventor: Robert Britton , Adluri Bharanishashank , Michael Meanwell , Steven Silverman
IPC: C07H1/00 , C07H19/067
Abstract: The present invention relates to methods and intermediates for the synthesis of nucleosides and nucleoside analogues (NAs). More specifically, the present invention relates to methods of synthesizing nucleosides and NAs, using simple achiral materials by a ‘one-pot’ proline-catalyzed halogenation of a heteroaryl-substituted acetaldehyde together with a tandem enantioselective aldol reaction followed by a reduction or organometallic addition and cyclization (annulation) reaction involving halide displacement.
-
公开(公告)号:US11566051B2
公开(公告)日:2023-01-31
申请号:US16964118
申请日:2019-01-24
Applicant: Merck Sharp & Dohme Corp. , Lan Zhang , Arthur Fridman , Eberhard Durr , Andrew Bett
Inventor: Lan Zhang , Arthur Fridman , Eberhard Durr , Andrew Bett
IPC: C07K14/135 , A61K39/155 , C12N7/00 , A61K39/00
Abstract: The disclosure relates to stable RSV F proteins and immunogenic compositions containing the same, as well as methods of using the immunogenic compositions and compositions comprising the RSV F proteins.
-
公开(公告)号:US11545270B1
公开(公告)日:2023-01-03
申请号:US16748800
申请日:2020-01-21
Applicant: Merck Sharp & Dohme Corp.
Abstract: A dossier change control management system periodically ingests data regarding a regulated product from multiple data stores. The dossier change control management system updates dossier data describing a dossier history for the regulated product using the received data. The dossier includes multiple documents in a standardized format and is updated based on a data mapping indicating correspondence between fields of the documents and portions of the received data. An out-of-expectation scenario for the dossier is identified based on regulatory requirements and an alert generated. A report with information about the out-of-expectation scenario is provided for display at a client device based on the alert.
-
公开(公告)号:US11542505B1
公开(公告)日:2023-01-03
申请号:US17047271
申请日:2019-04-15
Applicant: Merck Sharp & Dohme Corp. , Craig A. Parish , Hongwu Wang , Wonsuk Chang , Quang T. Truong , Tony Siu , Anne Mai Wassermann
Inventor: Craig A. Parish , Hongwu Wang , Wonsuk Chang , Quang T. Truong , Tony Siu , Anne Mai Wassermann
IPC: C12N15/113 , C07H21/02
Abstract: This invention provides compositions, compounds, and uses thereof, wherein said compounds comprise a single strand oligonucleotide that may form a short oligonucleotide hairpin or stem loop molecule with self complementary base pairing of less than 12 base pairs that bind to RIG-I and activate the RIG-I pathway.
-
-
-
-
-
-
-
-
-